Intranasal Drug Delivery to the Central Nervous System: Present Status and Future Outlook

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|3|510-526

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.3, 2013-01, pp. : 510-526

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intranasal delivery of growth differentiation factor 5 to the central nervous system

By Hanson Leah R.   Fine Jared M.   Hoekman John D.   Nguyen Thuhien M.   Burns Rachel B.   Martinez Paula M.   Pohl Jens   Frey William H.  

Drug Delivery, Vol. 19, Iss. 3, 2012-04 ,pp. : 149-154

Informa Healthcare

Access to resources Recommend Favorite

Current Approaches for Drug Delivery to Central Nervous System

By  

Current Drug Delivery, Vol. 7, Iss. 5, 2010-12 ,pp. : 389-397

Bentham Science Publishers

Access to resources Recommend Favorite

Intranasal Treatment of Central Nervous System Dysfunction in Humans

By Chapman Colin   Frey William   Craft Suzanne   Danielyan Lusine   Hallschmid Manfred   Schiöth Helgi   Benedict Christian  

Pharmaceutical Research, Vol. 30, Iss. 10, 2013-10 ,pp. : 2475-2484

Springer Publishing Company

Access to resources Recommend Favorite

Harnessing the Capacity of Cell-Penetrating Peptides for Drug Delivery to the Central Nervous System

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 3, 2014-03 ,pp. : 220-230

Bentham Science Publishers

Access to resources Recommend Favorite

A Focus on Glucose-Mediated Drug Delivery to the Central Nervous System

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 4, 2012-04 ,pp. : 301-312

Bentham Science Publishers

Access to resources Recommend Favorite